290 related articles for article (PubMed ID: 31141879)
21. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
[TBL] [Abstract][Full Text] [Related]
22. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR.
Willy PJ; Mangelsdorf DJ
Genes Dev; 1997 Feb; 11(3):289-98. PubMed ID: 9030682
[TBL] [Abstract][Full Text] [Related]
23. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
[TBL] [Abstract][Full Text] [Related]
25. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
Cavaillès V; Gompel A; Portois MC; Thénot S; Mabon N; Vignon F
J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
[TBL] [Abstract][Full Text] [Related]
26. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
28. Regulation of aromatase by nuclear receptors.
Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
Wan YJ; Cai Y; Magee TR
Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
[TBL] [Abstract][Full Text] [Related]
30. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
Yao PL; Morales JL; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2014 Apr; 13(4):1008-17. PubMed ID: 24464939
[TBL] [Abstract][Full Text] [Related]
31. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
32. Functional interference between estrogen-related receptor alpha and peroxisome proliferator-activated receptor alpha/9-cis-retinoic acid receptor alpha heterodimer complex in the nuclear receptor response element-1 of the medium chain acyl-coenzyme A dehydrogenase gene.
Maehara K; Hida T; Abe Y; Koga A; Ota K; Kutoh E
J Mol Endocrinol; 2003 Aug; 31(1):47-60. PubMed ID: 12914524
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
34. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
35. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
36. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells.
Mu YM; Yanase T; Nishi Y; Hirase N; Goto K; Takayanagi R; Nawata H
Mol Cell Endocrinol; 2000 Aug; 166(2):137-45. PubMed ID: 10996432
[TBL] [Abstract][Full Text] [Related]
37. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
van der Leede BM; van den Brink CE; van der Saag PT
Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
Kang JH; Chung JK; Lee YJ; Kim KI; Jeong JM; Lee DS; Lee MC
Nucl Med Commun; 2006 Oct; 27(10):773-7. PubMed ID: 16969258
[TBL] [Abstract][Full Text] [Related]
40. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
